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Proportion
referred to
GC (%)
(n ¼ 350)
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who underwent
genetic
counseling and
testing (%)
(n ¼ 268)
Proportion
with LS (%)
(n ¼ 101)*
CRC only 294 214 (73%) 165 (77%) 69 (42%)
Endometrial only 161 131 (81%) 93 (71%) 16 (16%)
CRC and endometrial 18 15 (83%) 10 (67%) 8 (80%)
*p<0.01RESULTS OF A SELECTIVE SCREENING APPROACH FOR LYNCH SYN-
DROME: NEED FOR STANDARDIZATION?
Vanessa W. Hui, Rachel A. Levy, Jose G. Guillem. Department of Surgery,
Memorial Sloan-Kettering Cancer Center, USA.
Introduction: Lynch Syndrome (LS) is associated with increased risk of
developing cancers, particularly endometrial and colorectal cancer (CRC).
Currently, we selectively screen for LS by looking for loss of mismatch
repair (MMR) proteins in resected cancers. We examined the efﬁcacy of a
physician-based genetic counseling (GC) referral program for detecting
LS.
Methods: Pathology reports from 2628 CRC and/or endometrial cancer
patients who underwent testing for loss of MMR protein expression be-
tween 2006 and 2013 were reviewed. Clinical and genetic data were
extracted from medical records.
Results: Abnormal MMR expression was found in 473 (18%) patients with
CRC and/or endometrial cancer. Rates of GC referral and LS detection were
stratiﬁed by cancer types:Conclusion: Though the overall referral rate to GC can be improved, the
referral rates are similar across cancer types. Given the two- to four-fold
higher likelihood of LS in patients with both CRC and endometrial cancer
than in patients with either cancer alone, clinicians should recognize the
need for GC referral in these patients.
